Clinical Trials for Celyad Oncology

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Celyad Oncology

Clinical Trials (4)

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

PHASE1Recruiting

34 participants

Started: Nov 22, 2021 · Completed: May 25, 2038

1 condition2 sponsors5 locations

Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma

PHASE1Active, not recruiting

18 participants

Started: Nov 16, 2020 · Completed: Feb 28, 2037

1 condition1 sponsor5 locations

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

PHASE1Recruiting

27 participants

Started: Nov 25, 2019 · Completed: Feb 28, 2035

2 conditions1 sponsor5 locations

alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

PHASE1Recruiting

49 participants

Started: Nov 28, 2018 · Completed: Feb 17, 2036

1 condition1 sponsor4 locations